Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 41251-41300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06544785
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2Recruiting
106 participants
Started: Sep 2, 2024 · Completed: May 31, 2032
2 conditions1 sponsor1 location
NCT06565026
CS-206 in Patients With Sickle Cell Disease
EARLY_PHASE1Recruiting
5 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06215989
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NARecruiting
6,574 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2028
5 conditions1 sponsor1 location
NCT06283719
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
PHASE1/PHASE2Recruiting
105 participants
Started: Sep 2, 2024 · Completed: Apr 30, 2026
2 conditions1 sponsor1 location
NCT06576440
Effects of Ghrelin Administration on Motivation
NAEnrolling by invitation
40 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06292585
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
NARecruiting
194 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06579937
Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy
PHASE4Recruiting
172 participants
Started: Sep 2, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor1 location
NCT06575179
Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum
PHASE4Recruiting
90 participants
Started: Sep 2, 2024 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05851534
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NARecruiting
2,575 participants
Started: Sep 2, 2024 · Completed: Sep 2, 2028
4 conditions2 sponsors13 locations
NCT06658223
Effects of Immersive Virtual Reality in Fibromyalgia
NAEnrolling by invitation
30 participants
Started: Sep 2, 2024 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT06616467
Cognitive-Behavioral Intervention to Increase Tummy Time Practice and Maintain Healthy Weight in Infants
NAActive, not recruiting
144 participants
Started: Sep 2, 2024 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT07057687
Non-Specific Chronic Low Back Pain Treatment Methods
NAActive, not recruiting
45 participants
Started: Sep 2, 2024 · Completed: Jun 25, 2026
1 condition2 sponsors1 location
NCT06622629
Nature Based Therapy With Mindful Walks in Urban Coastal Settings - Barcelona (Spain)
NAActive, not recruiting
100 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06501807
BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry
NANot yet recruiting
900 participants
Started: Sep 2, 2024 · Completed: Jan 2, 2035
2 conditions1 sponsor1 location
NCT06389773
Teamwork for Resilient Staff and Safe Care in ICU
N/ANot yet recruiting
75 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor0 locations
NCT06612359
Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
PHASE1Recruiting
12 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT06861127
Role of MRI in Diagnosis of Postpartum Neurological Disorders
N/AActive, not recruiting
50 participants
Started: Sep 2, 2024 · Completed: Oct 2, 2025
1 condition1 sponsor1 location
NCT06026592
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
N/ARecruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 9, 2026
2 conditions1 sponsor1 location
NCT06756438
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NARecruiting
88 participants
Started: Sep 2, 2024 · Completed: Sep 1, 2025
2 conditions1 sponsor1 location
NCT06822621
Functional Cereal Products and Contribution to the Regulation of Metabolism and Obesity-induced Chronic Low-grade Inflammation.
NAEnrolling by invitation
60 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2025
2 conditions2 sponsors1 location
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
PHASE1Recruiting
138 participants
Started: Sep 2, 2024 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06481527
Seen and Be Heard: Ensuring Fair Cancer Care for All Children
N/ANot yet recruiting
50 participants
Started: Sep 2, 2024 · Completed: Mar 1, 2026
3 conditions2 sponsors0 locations
NCT06775548
Comparing the Effects of Aerobic & Resistance Exercises and Vitamins D & E on Oxidative Stress & Inflammatory Markers Among Patients with Depression
NAEnrolling by invitation
116 participants
Started: Sep 2, 2024 · Completed: Aug 5, 2025
1 condition1 sponsor1 location
NCT06762015
Nursing Practice Environment and Patient Safety in Primary Health Care
NAActive, not recruiting
45 participants
Started: Sep 2, 2024 · Completed: Apr 30, 2025
3 conditions3 sponsors1 location
NCT06748027
Guidelines on Long-term Medical Fasting
N/AEnrolling by invitation
60 participants
Started: Sep 2, 2024 · Completed: Dec 1, 2025
2 conditions4 sponsors1 location
NCT06477536
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
PHASE2/PHASE3Recruiting
33 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06142682
Dexamethasone Eluting Cochlear Implant: a Pivotal Study
NARecruiting
60 participants
Started: Sep 2, 2024 · Completed: May 30, 2026
1 condition1 sponsor7 locations
NCT07114809
Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis
NARecruiting
80 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2026
2 conditions2 sponsors3 locations
NCT07122960
Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research
NARecruiting
60 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT07077642
Validation of a Multidimensional Scale for the Detection of Health Needs in People With HIV
N/AEnrolling by invitation
200 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor11 locations
NCT06309641
Methemoglobinemia Following Intravenous Iron Treatment
N/ARecruiting
80 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06138990
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
PHASE2Recruiting
88 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT06591598
A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
PHASE4Active, not recruiting
51 participants
Started: Sep 2, 2024 · Completed: Oct 29, 2025
2 conditions2 sponsors8 locations
NCT06594250
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
N/ARecruiting
405 participants
Started: Sep 2, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06590103
Effectiveness of Integrating Physically Active Learning Through Co-teaching in Extremadura: ACTIVA-MENTE Project
NARecruiting
800 participants
Started: Sep 2, 2024 · Completed: Jun 15, 2025
3 conditions2 sponsors1 location
NCT06560489
Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients
PHASE1/PHASE2Enrolling by invitation
40 participants
Started: Sep 2, 2024 · Completed: May 20, 2025
1 condition2 sponsors1 location
NCT06598488
Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women?
NARecruiting
20 participants
Started: Sep 2, 2024 · Completed: Jan 1, 2028
1 condition1 sponsor1 location
NCT06595667
Fluid Responsiveness in Posterior Fossa Tumor Resection: PPV and CVP Guidance
NAActive, not recruiting
50 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT06614790
Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
N/ARecruiting
300 participants
Started: Sep 2, 2024 · Completed: Jan 7, 2026
1 condition1 sponsor12 locations
NCT06412614
Evaluation of Patients With Systemic Sclerosis Without Specific or Associated Autoantibodies
N/ANot yet recruiting
300 participants
Started: Sep 2, 2024 · Completed: Jun 29, 2025
1 condition1 sponsor14 locations
NCT06545812
Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation
NARecruiting
128 participants
Started: Sep 2, 2024 · Completed: Mar 2, 2026
4 conditions1 sponsor1 location
NCT06667414
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
N/ARecruiting
600 participants
Started: Sep 2, 2024 · Completed: Sep 24, 2028
1 condition1 sponsor44 locations
NCT06641856
Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
N/ARecruiting
300 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06576375
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
PHASE3Recruiting
70 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2025
1 condition2 sponsors1 location
NCT06539286
Dentin Hypersensitivity - Varnish or Laser?
NANot yet recruiting
80 participants
Started: Sep 2, 2024 · Completed: Dec 14, 2024
1 condition1 sponsor0 locations
NCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
NARecruiting
40 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT06736275
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
EARLY_PHASE1Active, not recruiting
8 participants
Started: Sep 2, 2024 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT06559501
Integrated Case Management for Burns Care in Pakistan
NARecruiting
1,146 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2026
4 conditions2 sponsors11 locations
NCT06490757
A Phase 2 Open-label Single-arm Trial of JAK1 Inhibitor for the Treatment of Large Inflammatory Hepatocellular Adenomas
PHASE2Not yet recruiting
25 participants
Started: Sep 2, 2024 · Completed: Sep 2, 2028
1 condition1 sponsor0 locations
NCT06733064
Strenght Training in Osteoporosis Prevention
NAActive, not recruiting
120 participants
Started: Sep 2, 2024 · Completed: Jan 30, 2026
1 condition1 sponsor2 locations